added. The reaction mixture was stirred for 220 min at room
temperature. 2ꢀ,5ꢀ-Di-O-methyluridine (5, 0.81 mmol, 0.22 g)
was coevaporated three times from anhydrous pyridine and
once from anhydrous MeCN, and the residue was added to the
reaction mixture, together with anhydrous MeCN (1.0 mL) and
tetrazole (1.43 mmol, 0.1 g). The reaction mixture was stirred for
temperature, the reaction mixture was evaporated to dryness.
A conventional CH2Cl2–aq. NaHCO3 workup was carried out
and the combined organic phases were evaporated to dryness.
Approximately half of the residue (1.12 mmol, 0.6264 g)
and 2ꢀ,5ꢀ-di-O-methyluridine (5, 1.23 mmol, 0.3355 g) were
coevaporated once from anhydrous MeCN and the residue
was dissolved in anhydrous MeCN. A solution of tetrazole
(1.26 mmol, 0.0882 g) in MeCN (2.8 mL) was added and
the reaction mixture was stirred for 4 h at room temperature.
Iodine (2.0 mmol, 0.52 g) in a mixture of THF (9.2 mL),
water (4.6 mL) and 2,6-lutidine (2.3 mL) was added and the
reaction mixture was stirred for an additional 2 h at room
temperature, after which it was concentrated under reduced
pressure. A CH2Cl2–aq. NaHSO3 workup was carried out and
the combined organic phases were evaporated to dryness. The
product (a mixture of isomers) was purified on a silica gel
column eluting with a mixture of CH2Cl2 and MeOH (95 : 5,
v/v). The crude product mixture thus obtained was dissolved in
saturated methanolic ammonia (15 mL). After being stirred for
4 h at room temperature, the reaction mixture was evaporated
to dryness. The residue was dissolved in a mixture of acetic
acid (6 mL), water (2 mL) and THF (6 mL) and the reaction
mixture was stirred for 23 h at room temperature, after which it
was reduced to dryness. The products were purified by HPLC
on a Supelcosil LC-18 column (25 cm × 21.2 mm, 12 lm)
eluting with a mixture of 0.06 mol L−1 of aqueous NaOAc and
MeCN (89 : 11, v/v). Finally the buffer salts were removed
on the same column by eluting with a mixture of water and
MeCN (87 : 13, v/v). The overall yields starting from 2ꢀ(3ꢀ)-
O-isopropyldimethylsilyl-5ꢀ-O-methyluridine 3ꢀ(2ꢀ)-(2-cyano-
ethyl-N,N-diisopropylphosphoramidite) were 2.4% (18.6 mg)
◦
25 h at 50 C. 3ꢀ-O-(4,4ꢀ-Dimethoxytrityl)-5ꢀ-O-methyluridine
(4b, 1.04 mmol, 0.58 g) was coevaporated three times from
anhydrous pyridine and once from anhydrous MeCN, and
the residue was added to the reaction mixture, together with
tetrazole (1.14 mmol, 0.080 g). The reaction mixture was stirred
for 24 h at 40 ◦C, after which iodine (0.51 mmol, 0.13 g)
in a mixture of water (2.4 mL), THF (4.8 mL) and 2,6-
lutidine (1.2 mL) was added. After being stirred for 90 min at
room temperature the reaction mixture was concentrated under
reduced pressure and the residue was dissolved in saturated aq.
NaHSO3 (40 mL). The mixture was extracted with CH2Cl2 and
the organic phase was dried with Na2SO4 and evaporated to
dryness. The product was purified on a silica gel column eluting
with a mixture of MeOH, Et3N and CH2Cl2 (2 : 1 : 97, v/v).
The crude material thus obtained was dissolved in saturated
methanolic ammonia (10 mL). The reaction mixture was stirred
for 6 h at room temperature, after which it was evaporated to
dryness. The product was purified first on a silica gel column
eluting with a mixture of MeOH, Et3N and CH2Cl2 (4 : 1 : 95,
v/v), then by HPLC on a Supelcosil LC-18 column (25 cm ×
21.2 mm, 12 lm) eluting with a mixture of 0.05 mol L−1 of
aqueous NH4OAc and MeCN (53 : 47, v/v). Finally the buffer
salts were removed on the same column by eluting with a mixture
of water and MeCN (45 : 55, v/v). Compound 2b was obtained
as two diastereomers in approximately 1 : 1 ratio. A good
separation of the diastereomers was achieved by HPLC. The
1
and 4.5% (34.9 mg) for 9a and 9b, respectively. H NMR (dH)
1
overall yield starting from 6 was 11% (103 mg). H NMR (dH)
(400 MHz, DMSO-d6, 9a) 7.72 (d, 1H, J = 8.2 Hz), 7.66 (d, 1H,
J = 8.1 Hz), 5.85 (d, 1H, J = 5.8 Hz), 5.81 (d, 1H, J = 6.9 Hz),
5.70 (d, 1H, J = 8.1 Hz), 5.69 (d, 1H, J = 8.1 Hz), 4.56 (m, 1H),
4.54 (s, 1H), 4.38 (m, 1H), 4.18 (m, 1H), 4.13–4.08 (m, 2H),
3.90 (dd, 1H, J1 = 5.2 Hz, J2 = 5.9 Hz), 3.59–3.44 (m, 4H),
3.34 (s, 3H), 3.32 (s, 3H), 3.30 (s, 3H). 1H NMR (dH) (400 MHz,
DMSO-d6, 9b) 7.68 (d, 1H, J = 8.2 Hz), 7.67 (d, 1H, J = 8.2 Hz),
5.86 (d, 1H, J = 4.5 Hz), 5.85 (d, 1H, J = 6.3 Hz), 5.71 (d, 1H,
J = 8.1 Hz), 5.66 (d, 1H, J = 8.0 Hz), 4.54 (s, 1H), 4.52 (m,
1H), 4.41 (m, 1H), 4.18 (m, 1H), 4.10 (dd, 1H, J1 = 5.6 Hz, J2 =
5.6 Hz), 3.55–3.38 (m, 4H), 3.30 (s, 3H), 3.28 (s, 3H), 3.25 (s,
3H). 31P NMR (dP) (202 MHz, DMSO-d6, 9a) −0.55. 31P NMR
(dP) (202 MHz, DMSO-d6, 9b) −0.82. ESI−-MS (9a): m/z 591.5
[M − H]−. ESI−-MS (9b): m/z 591.2 [M − H]−.
5ꢀ-O-Methyluridylyl-(3ꢀ,5ꢀ)-(2ꢀ,3ꢀ-O-methyleneadenosine), 5ꢀ-
O-methyluridylyl-(2ꢀ,5ꢀ)-(2ꢀ,3ꢀ -O-methyleneadenosine) (10a,b).
A mixture of 2ꢀ-O-isopropyldimethylsilyl-5ꢀ-O-methyluridine
3ꢀ-(2-cyanoethyl-N,N-diisopropylphosphoramidite) and 3ꢀ -O-
isopropyldimethylsilyl-5ꢀ -O-methyluridine 2ꢀ -(2-cyanoethyl-
N,N-diisopropylphosphoramidite) (see the synthesis of 9a,b
above, 1.01 mmol, 0.6072 g) and N6-benzoyl-2ꢀ,3ꢀ-O-methylene-
adenosine (6, 1.21 mmol, 0.4671 g) were coevaporated once
from anhydrous MeCN. To the residue, a solution of tetrazole
(1.22 mmol, 0.085 g) in MeCN (5.7 mL) was added and the
reaction mixture was stirred for 4 h at room temperature.
Iodine (2.0 mmol, 0.52 g) in a mixture of THF (9.2 mL),
water (4.6 mL) and 2,6-lutidine (2.3 mL) was added and the
reaction mixture was stirred for an additional 2 h at room
temperature, after which it was concentrated under reduced
pressure. A CH2Cl2–aq. NaHSO3 workup was carried out and
the combined organic phases were evaporated to dryness. The
product (a mixture of isomers) was purified on a silica gel
column eluting with a mixture of CH2Cl2 and MeOH (95 : 5,
v/v). The crude product mixture thus obtained was dissolved in
saturated methanolic ammonia (15 mL). After being stirred for
5 h at room temperature the reaction mixture was evaporated
to dryness. The residue was dissolved in a mixture of acetic
(500 MHz, DMSO-d6, first diastereomer) 8.35 (s, 1H), 8.13
(s, 1H), 7.64 (d, 1H, J = 8.2 Hz), 7.54 (d, 1H, J = 8.2 Hz), 7.48–
6.87 (m, 15H), 6.28 (d, 1H, J = 7.0 Hz), 6.21 (d, 1H, J = 2.8 Hz),
5.79 (d, 1H, J = 6.5 Hz), 5.73 (d, 1H, J = 8.1 Hz), 5.71 (d, 1H,
J = 8.1 Hz), 5.28 (dd, 1H, J1 = 2.9 Hz, J2 = 6.7 Hz), 5.17
(s, 1H), 5.13 (s, 1H), 4.99 (dd, 1H, J1 = 4.0 Hz, J2 = 6.6 Hz),
4.85 (m, 1H), 4.78 (m, 1H), 4.35 (m, 1H), 4.27 (m, 2H), 4.12
(m, 1H), 4.04 (m, 1H), 3.73 (s, 3H), 3.72 (s, 3H), 3.45–3.30
1
(m, 6H), 3.29 (s, 3H), 3.24 (s, 3H), 3.03 (s, 3H). H NMR (dH)
(500 MHz, DMSO-d6, second diastereomer) 8.29 (s, 1H), 8.08 (s,
1H), 7.64 (d, 1H, J = 8.2 Hz), 7.56 (d, 1H, J = 8.2 Hz), 7.53–6.87
(m, 15H), 6.24 (d, 1H, J = 2.6 Hz), 6.20 (d, 1H, J = 6.0 Hz), 5.88
(d, 1H, J = 6.4 Hz), 5.73 (dd, 1H, J1 = 2.1 Hz, J2 = 8.1 Hz), 5.69
(dd, 1H, J1 = 2.0 Hz, J2 = 8.0 Hz), 5.27 (dd, 1H, J1 = 2.7 Hz, J2 =
6.5 Hz), 5.17 (s, 1H), 5.14 (s, 1H), 5.03 (dd, 1H, J1 = 3.8 Hz, J2 =
6.4 Hz), 4.89 (m, 1H), 4.49 (m, 1H), 4.33 (m, 1H), 4.31–4.24
(m, 2H), 4.17 (m, 1H), 4.04 (m, 1H), 3.73 (s, 3H), 3.72 (s, 3H),
3.46–3.23 (m, 6H), 3.31 (s, 3H), 3.25 (s, 3H), 3.06 (s, 3H). 31P
NMR (dP) (202 MHz, DMSO-d6, first diastereomer) −1.84. 31
HRMS (FAB) M− calcd 1154.3508, obsd 1154.3540.
P
NMR (dP) (202 MHz, DMSO-d6, second diastereomer) −2.07.
5ꢀ-O-Methyluridylyl-(3ꢀ,3ꢀ)-(2ꢀ,5ꢀ-di-O-methyluridine), 5ꢀ-O-
methyluridylyl-(2ꢀ,3ꢀ)-(2ꢀ,5ꢀ-di-O-methyluridine) (9a,b). 5ꢀ-O-
Methyluridine (7, 26.0 mmol, 6.7 g) was dissolved in anhydrous
pyridine (100 mL) and chlorodimethylisopropylsilane
(26.7 mmol, 4.2 L) was added. The reaction mixture was
stirred for 2 h at 40 ◦C, after which it was evaporated to dryness.
A conventional aq. NaHCO3–CH2Cl2 workup was carried out
and the product was purified on a silica gel column eluting
with a mixture of MeOH, Et3N and CH2Cl2 (5 : 1 : 94, v/v).
The isomers were not separated at this point. The isomeric
mixture (2.52 mmol, 0.9015 g) was coevaporated once from
anhydrous pyridine. To the residue 2-cyanoethyl-N,N,Nꢀ,Nꢀ-
tetraisopropylphosphorodiamidite (3.15 mmol, 1.0 mL)
and a solution of tetrazole (2.79 mmol, 0.195 g) in MeCN
(6.2 mL) were added. After being stirred for 90 min at room
O r g . B i o m o l . C h e m . , 2 0 0 5 , 3 , 1 0 8 9 – 1 0 9 6
1 0 9 5